{
  "url": "https://openlegislation.uk/misuse-of-drugs-amendment-regulations-2003/regulation-2",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-amendment-regulations-2003/regulation-2.json",
  "legislation": "uksi/2003/1432",
  "legislation_title": "The Misuse of Drugs (Amendment) Regulations 2003",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-amendment-regulations-2003",
  "path": "regulation/2",
  "kind": "regulation",
  "number": "2",
  "heading": null,
  "text": "(1) The Misuse of Drugs Regulations 2001, shall be amended as follows.\n(2) In paragraph 1 of Schedule 2 there shall be inserted—\n(a) after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and\n(b) after “Racemorphan”, “Remifentanil”.\n(3) In paragraph 1, Part 1 of Schedule 4 there shall be inserted—\n(a) after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and\n(b) after “N-Ethylamphetamine”, “Zolpidem”.\n(4) In paragraph 1, Part II of Schedule 4 there shall be inserted—\n(a) before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17 diol”; and\n(b) after “Nandrolone”, “19-Nor-4-Androstene-3, 17-dione” and “19-Nor-5-Androstene-3, 17 diol”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 2001/3998."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2003/1432/regulation/2",
    "retrieved_at": "2026-10-29T06:23:14.088670+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}